The Glucagon-Like Peptide-1 Analogue Liraglutide Reduces Seizures Susceptibility, Cognition Dysfunction and Neuronal Apoptosis in a Mouse Model of Dravet Syndrome

Dravet syndrome (DS) is a refractory epilepsy typically caused by heterozygous mutations of the Scn1a gene, which encodes the voltage-gated sodium channel Nav1.1. Glucagon-like peptide-1 (GLP-1) analogues, effective therapeutic agents for the treatment of diabetes, have recently become attractive tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shenhai, Jin, Zhe, Zhang, Yiling, Rong, ShiKuo, He, Wenxin, Sun, Kuisheng, Wan, Din, Huo, Junming, Xiao, Lifei, Li, Xinxiao, Ding, Na, Wang, Feng, Sun, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059191/
https://www.ncbi.nlm.nih.gov/pubmed/32184723
http://dx.doi.org/10.3389/fphar.2020.00136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059191/
https://www.ncbi.nlm.nih.gov/pubmed/32184723
http://dx.doi.org/10.3389/fphar.2020.00136

Ejemplares similares